Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹69.2 Cr -2.3% NA -42.9% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,083.7 Cr -1.6% 0.5% 0.8% Stock Analytics
KIRI INDUSTRIES ₹2,737.3 Cr 1.1% -5.5% -16% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,541.6 Cr -2.2% -1.5% -30.7% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,084.3 Cr -4.9% -4.7% 13.4% Stock Analytics
BODAL CHEMICALS ₹607.2 Cr 0.1% 1.7% -21.5% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-2.3%

NA

-42.9%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses